We are live on
!
Find out more
HA
HHLR Advisors Portfolio holdings
AUM
$1.67B
1-Year Est. Return
7.53%
This Fund
S&P 500
This Quarter
Est. Return
+1.39%
1 Year Est. Return
+7.53%
3 Year Est. Return
+82.23%
5 Year Est. Return
+55.28%
10 Year Est. Return
–
AUM
$10.1B
AUM Growth
-$2.46B
(-20%)
Cap. Flow
-$2.33B
Cap. Flow
% of AUM
-23.06%
Top 10 Holdings %
Top 10 Hldgs %
66.26%
Holding
108
New
13
Increased
9
Reduced
29
Closed
17
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NBP
NovaBridge Biosciences American Depositary Shares
NBP
|
+$278M |
| 2 |
Playtika
PLTK
|
+$96.5M |
| 3 |
Instil Bio
TIL
|
+$61.2M |
| 4 |
TUYA
Tuya Inc
TUYA
|
+$52M |
| 5 |
BridgeBio Pharma
BBIO
|
+$42.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JD.com
JD
|
+$864M |
| 2 |
Zoom
ZM
|
+$370M |
| 3 |
TAL Education Group
TAL
|
+$290M |
| 4 |
Uber
UBER
|
+$274M |
| 5 |
Bilibili
BILI
|
+$249M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 39.49% |
| 2 | Consumer Discretionary | 20.09% |
| 3 | Technology | 16.32% |
| 4 | Communication Services | 9.51% |
| 5 | Financials | 5.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ONC
1
BeOne Medicines Ltd
ONC
$34B
| $1.9B | 18.82% |
5,472,259
| – | – |
|
2
Pinduoduo
PDD
$125B
| $1.37B | 13.53% |
10,222,922
-7,110
| -0.1% | -$1.2M |
|
3
iQIYI
IQ
$1.2B
| $642M | 6.35% |
38,648,477
| – | – |
|
|
4
Zoom
ZM
$27B
| $635M | 6.27% |
1,975,966
-1,005,299
| -34% | -$370M |
|
|
ESGR
5
DELISTED
Enstar Group
ESGR
| $431M | 4.26% |
1,747,840
| – | – |
|
|
6
Uber
UBER
$143B
| $370M | 3.66% |
6,791,449
-4,907,121
| -42% | -$274M |
|
|
7
JD.com
JD
$43.2B
| $351M | 3.47% |
4,162,336
-9,422,705
| -69% | -$864M |
|
|
CBPO
8
DELISTED
China Biologic Products Holdings, Inc.
CBPO
| $351M | 3.47% |
2,962,076
| – | – |
|
|
9
BridgeBio Pharma
BBIO
$16.6B
| $330M | 3.26% |
5,362,014
+650,410
| +14% | +$42.6M |
|
|
NBP
10
NovaBridge Biosciences American Depositary Shares
NBP
$193M
| $321M | 3.17% |
6,616,170
+5,119,630
| +342% | +$278M |
|
11
KE Holdings
BEKE
$17.7B
| $286M | 2.82% |
5,012,100
+12,100
| +0.2% | +$761K |
|
12
GDS Holdings
GDS
$5.91B
| $255M | 2.52% |
3,143,623
| – | – |
|
13
Salesforce
CRM
$153B
| $241M | 2.38% |
1,136,476
+64,381
| +6% | +$14.3M |
|
|
14
Bilibili
BILI
$7.81B
| $214M | 2.11% |
1,998,271
-2,036,764
| -50% | -$249M |
|
|
APLS
15
DELISTED
Apellis Pharmaceuticals
APLS
| $196M | 1.93% |
4,558,029
-470,260
| -9% | -$22.3M |
|
16
Beam Therapeutics
BEAM
$2.66B
| $166M | 1.64% |
2,072,679
-893,724
| -30% | -$85M |
|
17
DoorDash
DASH
$85B
| $144M | 1.42% |
1,096,300
+237,800
| +28% | +$39.8M |
|
|
KYNB
18
Kyntra Bio
KYNB
$28.2M
| $137M | 1.36% |
158,231
| – | – |
|
19
Mondelez International
MDLZ
$84.2B
| $109M | 1.08% |
1,862,164
-193,600
| -9% | -$10.9M |
|
20
argenx
ARGX
$55.4B
| $103M | 1.02% |
375,540
-94,460
| -20% | -$29.9M |
|
21
Kodiak Sciences
KOD
$2.42B
| $101M | 1% |
888,627
-268,780
| -23% | -$36.7M |
|
|
22
Playtika
PLTK
$1.53B
| $89.3M | 0.88% |
+3,280,699
| New | +$96.5M |
|
23
ZTO Express
ZTO
$18.3B
| $75.8M | 0.75% |
2,600,777
-744,698
| -22% | -$24.3M |
|
|
BPMC
24
DELISTED
Blueprint Medicines
BPMC
| $73.8M | 0.73% |
758,691
-511,838
| -40% | -$51.1M |
|
25
Gossamer Bio
GOSS
$97.4M
| $68.6M | 0.68% |
7,420,974
| – | – |
|
Similar funds
TFS
GC
PA
LCI
JPM
NRI
CPO
JIP
HHLR Advisors's Q1 2021 Portfolio in Review
As of Q1 2021, HHLR Advisors held 108 positions worth $10.1B, down 20% from $12.6B the previous quarter. Its ten largest holdings account for 66% of the portfolio.
HHLR Advisors withdrew a net $2.33B in Q1 2021, closing 17 positions and reducing 29 holdings. Its most notable exit was TAL Education Group, an estimated $290M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 39% of assets, up from 32% a quarter earlier, followed by Consumer Discretionary and Technology.
Against the trend, HHLR Advisors opened a new position in Playtika worth $89.3M.
- HHLR Advisors's largest Q1 2021 buy was Playtika: 3,280,699 shares worth $89.3M.
- HHLR Advisors added most to NovaBridge Biosciences American Depositary Shares in Q1 2021, an estimated $278M increase.
- HHLR Advisors's biggest Q1 2021 reduction was JD.com, cutting an estimated $864M.
- HHLR Advisors fully exited TAL Education Group in Q1 2021, selling an estimated $290M.
- HHLR Advisors's ten largest holdings make up 66% of its $10.1B portfolio in Q1 2021.
- HHLR Advisors opened 13 new positions and closed 17 in Q1 2021.
- HHLR Advisors's portfolio value fell 20% quarter-over-quarter to $10.1B.
Based on HHLR Advisors's 13F filing for Q1 2021, filed 17 May 2021.